STOCK TITAN
  1. Home
  2. Sec-filings
  3. MYSZ
  4. [Form 4] My Size, Inc. Insider Trading Activity

My Size (MYSZ) CEO and spouse granted restricted stock awards under 2017 plan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

My Size, Inc. reported that its Chief Executive Officer and director, Ronen Luzon, received grants of restricted common stock under the company’s 2017 Equity Incentive Plan on December 15, 2025. He was granted 215,000 restricted shares at a price of $0, bringing his directly held beneficial ownership to 289,335 shares after the transaction. These awards include time-based vesting in three equal annual installments from January 1, 2026 through January 1, 2028, a tranche vesting on December 31, 2025, and performance-based vesting tied to profit and business targets, all subject to continued service.

Luzon also reported indirect ownership through his spouse, Chief Product Officer and Chief Operating Officer Billy Pardo. She received 60,000 restricted shares at a price of $0, increasing the indirectly beneficially owned common stock to 79,750 shares. Her awards follow similar time-based and performance-based vesting schedules under the same plan, conditioned on her continued service to My Size and achievement of specified business and profit targets.

Positive

  • None.

Negative

  • None.
Insider Luzon Ronen
Role Chief Executive Officer
Type Security Shares Price Value
Grant/Award Common Stock 215,000 $0.00 --
Grant/Award Common Stock 60,000 $0.00 --
Holdings After Transaction: Common Stock — 289,335 shares (Direct); Common Stock — 79,750 shares (Indirect, See Footnote)
Footnotes (1)
  1. Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan"). 75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date. Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date. 15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date. 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date. Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date. Common stock beneficially owned by Reporting Perosn's Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the Plan.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Luzon Ronen
(Last) (First) (Middle)
C/O MY SIZE INC.
HANEGEV 4, POB 1026
(Street)
AIRPORT CITY L3 7019900
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
My Size, Inc. [ MYSZ ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/15/2025 A 215,000(1)(2)(3)(4) A $0 289,335 D
Common Stock 12/15/2025 A 60,000(1)(5)(6) A $0 79,750 I See Footnote(7)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Restricted shares granted under the My Size, Inc. 2017 Equity Incentive Plan (the "Plan").
2. 75,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service to the Issuer as of each vesting date.
3. Up to 125,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's continued service to the Issuer as of each vesting date.
4. 15,000 restricted shares vest on December 31, 2025, subject to the Reporting Person's continued service to the Issuer as of such vesting date.
5. 40,000 restricted shares vest in three equal annual installments, with 1/3 vesting on each of January 1, 2026, January 1, 2027 and January 1, 2028, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.
6. Up to 20,000 restricted shares vest upon and subject to achievement of certain profit and business targets as set forth in the restricted stock agreement, subject to the Reporting Person's spouse continued service to the Issuer as of each vesting date.
7. Common stock beneficially owned by Reporting Perosn's Spouse (Chief Product Officer and Chief Operating Officer Billy Pardo) under the Plan.
/s/ Ronen Luzon 12/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did My Size (MYSZ) report for its CEO?

My Size reported that its Chief Executive Officer and director, Ronen Luzon, received a grant of 215,000 restricted shares of common stock on December 15, 2025 at a price of $0 under the company’s 2017 Equity Incentive Plan.

How many My Size (MYSZ) shares does the CEO beneficially own after this Form 4?

Following the reported transaction, Ronen Luzon beneficially owns 289,335 shares of My Size common stock directly and 79,750 shares indirectly through his spouse.

What are the vesting terms for the 215,000 restricted shares granted to the My Size CEO?

The grant includes 75,000 restricted shares vesting in three equal annual installments on January 1, 2026, January 1, 2027, and January 1, 2028; up to 125,000 restricted shares that vest upon achievement of specified profit and business targets; and 15,000 restricted shares vesting on December 31, 2025, all subject to his continued service.

What equity awards did the spouse of the My Size (MYSZ) CEO receive?

The CEO’s spouse, Billy Pardo (Chief Product Officer and Chief Operating Officer), received 60,000 restricted shares of common stock at $0, comprising 40,000 restricted shares that vest in three equal annual installments on January 1, 2026, January 1, 2027, and January 1, 2028, and up to 20,000 restricted shares that vest upon achievement of specified profit and business targets, subject to her continued service.

Under which plan were the My Size (MYSZ) restricted stock awards granted?

All of the reported restricted stock awards to Ronen Luzon and his spouse were granted under the My Size, Inc. 2017 Equity Incentive Plan.

Are the My Size (MYSZ) restricted stock awards performance-based or time-based?

The awards include both time-based vesting, with shares vesting on specified dates from December 31, 2025 through January 1, 2028, and performance-based vesting tied to achievement of profit and business targets, all requiring continued service to My Size.